| |
| |
|
| Insider
Information: |
Mileson Glenna |
| Relationship: |
Chief Financial Officer |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
159,930 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
159,930 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Athira Pharma, Inc. |
ATHA |
Chief Financial Officer |
2022-12-28 |
159,930 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATHA |
Athira Pharma, Inc. |
Chief Financial Officer |
• – – |
2022-12-28 |
4 |
B |
$2.85 |
$142,250 |
D/D |
50,000 |
159,930 |
2.74 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Financial Officer |
• – – |
2022-11-18 |
4 |
A |
$2.74 |
$2,091 |
D/D |
763 |
109,930 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Financial Officer |
• – – |
2022-06-23 |
4 |
S |
$2.69 |
$7,032 |
D/D |
(2,614) |
109,167 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Financial Officer |
• – – |
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
111,781 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Financial Officer |
• – – |
2022-05-18 |
4 |
A |
$7.06 |
$12,150 |
D/D |
1,721 |
101,781 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Financial Officer |
• – – |
2022-04-11 |
4 |
OE |
$10.64 |
$31,920 |
D/D |
3,000 |
100,060 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Financial Officer |
• – – |
2022-01-04 |
4 |
OE |
$1.35 |
$8,512 |
D/D |
6,305 |
97,060 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Financial Officer |
• – – |
2021-11-18 |
4 |
A |
$12.51 |
$11,647 |
D/D |
931 |
90,755 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Financial Officer |
• – – |
2021-06-10 |
4 |
OE |
$1.35 |
$8,512 |
D/D |
6,305 |
89,824 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Financial Officer |
• – – |
2021-05-18 |
4 |
A |
$14.45 |
$22,455 |
D/D |
1,554 |
83,519 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Financial OfficerOfficer |
• – – |
2020-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
81,965 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
